You are here

Optimising the treatment of mild to moderate UC

Bridging the gap between new evidence and daily practice

Ferring Symposium PC Output EDITED v1.0

Symposium sponsored by Ferring.

Jean-Frédéric Colombel, Mount Sinai Hospital, New York, USA

Geert D'Haens, Academic Medical Centre, Amsterdam, The Netherlands
Peter Irving, Guy’s and St Thomas' Hospital, London, UK
Neeraj Narula, Mount Sinai Hospital, New York USA

During this symposium, at the 10th Congress of ECCO, Barcelona, two interesting case studies were discussed. Advancements in improving existing treatment options can make a big difference for patients:

The concept of ‘window of opportunity’ in the early treatment of patients
New treatment targets – treating beyond remission to endoscopic healing
New data on new treatment options for the management of mild-to-moderate active ulcerative colitis